India Market Entry
Category assessment, route-to-market planning, pricing inputs and an India launch roadmap built around your goals.
Biome AesthetixTM
Pvt Ltd
Partner with us
India market access & distribution
From global innovation
to India-wide impact.
Biome Aesthetix is the India partner for aesthetic pharmaceuticals, medical devices and professional skincare—helping global innovators move from product registration to distribution, doctor engagement and sales through one connected team.
India focused
Integrated commercial
capabilities
capabilities
Key cities
Priority-market
network links
network links
End to end
Registration
to sales
to sales
Scroll to discover
01 About Biome
One India partner.
Every step covered.
Entering India should not mean managing a different partner for every stage of the journey.
Biome Aesthetix brings regulatory coordination, import and supply-chain management, distribution, brand building, doctor engagement and sales execution together under one accountable partnership. We combine pharmaceutical discipline with genuine understanding of India’s fast-evolving aesthetics market.
See our end-to-end model
G / 01
For global innovators
Your on-ground team for entering and scaling in India.
We translate global brand ambition into a practical regulatory, distribution and commercial plan for the Indian market.
I / 02
For Indian practitioners
A reliable bridge to trusted global innovation.
We support doctors and clinics with credible education, responsive service and a supply network designed for continuity.
02 End-to-end India solution
From registration
to revenue.
One integrated operating model that takes aesthetic businesses from India market planning to sustainable commercial growth.
Regulatory & Registration
Structured coordination of product classification, documentation, CDSCO pathways, licences and local compliance requirements.
Import & Supply Chain
Import coordination, demand planning, warehousing, cold-chain readiness where required and dependable fulfilment.
Distribution & Access
Channel design and reach across clinics, hospitals, pharmacies, institutions and qualified distribution partners.
Physician Engagement
Scientific positioning, KOL engagement, training, launch programs and credible communication for Indian practitioners.
Sales & Lifecycle
Field execution, account development, forecasting, reporting, customer support and long-term portfolio growth.
Indicative engagement pathway
Each opportunity is scoped product by product; stages and regulatory requirements vary by classification.
01
Opportunity screening
Category, evidence and India-fit review
02
Regulatory pathway
Product-specific classification and documentation plan
03
India business case
Pricing, channel and demand assumptions
04
Import readiness
Supply, quality and fulfilment workstream
05
Controlled launch
Practitioner education and field activation
06
Scale & lifecycle
Reporting, support and portfolio development
03 Product portfolio
Biome AesthetixTM
Innovating Aesthetics. Enhancing Lives.
Portfolio in development
Our first partner portfolio is taking shape.
We are currently evaluating selected global innovations for the Indian aesthetics market. Every opportunity is reviewed for regulatory fit, clinical relevance, quality, commercial potential and long-term value for practitioners.
Have an aesthetics brand ready for India—or want to hear about our first launches?
04 India market opportunity
India’s next aesthetics
growth cycle is being built now.
India combines an underpenetrated clinical-aesthetics market with rising urban demand and a shift toward more organized, practitioner-led care.
For global innovators, the opportunity is not only market size. It is the chance to enter early, localize scientific value and build category leadership as clinical channels and regulatory expectations mature.
Selected market forecasts
India / 2025-2036
Aesthetic devices
14.81% projected CAGR
2026
$0.87B
2031
$1.73B
Aesthetic injectables
12%+ projected CAGR
2025
$81.9M
2033
$205.5M
Pigmentation treatments
India growth forecast through 2036
Global
7.8%
India
9.7%
Why India, why now
Growth is moving toward clinically credible, locally relevant solutions.
- Clinical formalization Greater regulatory attention favors approved products, qualified practitioners and disciplined market partners.
- Skin-specific demand India’s diverse skin types increase the need for validated protocols, relevant technology and practitioner education.
- Expanding category depth Injectables, pigmentation, energy-based devices and emerging hair solutions create multiple routes to growth.
- Beyond the metros Organized dermatology networks and rising aesthetic awareness are extending demand across tier-1 and tier-2 cities.
Forecasts are third-party estimates and vary by category definition. Sources: Business Standard / Grand View Research, Mordor Intelligence and Future Market Insights.
The Biome advantage
Why build your India business with Biome?
India is not one market or one channel. Our team connects regulatory understanding, pharmaceutical operations and practitioner relationships so your brand can move with clarity from launch plan to everyday execution.
One integrated Biome team coordinates regulatory, supply-chain, commercial and field execution, giving your organization clear ownership and fewer hand-offs.
We help organize product classification, documentation, CDSCO pathways, licences and local compliance milestones with India-specific context and disciplined follow-through.
Structured forecasting, quality-conscious processes, channel governance and review rhythms bring established pharmaceutical standards to aesthetic-market execution.
A practical distribution model connects priority aesthetic markets through qualified channel relationships, responsive fulfilment and scalable territory planning.
Credible engagement with dermatologists, plastic surgeons and aesthetic practitioners helps brands earn trust through education, service and consistent presence.
Clinical evidence is translated into clear positioning, practitioner education, KOL programs and compliant communication tailored to the Indian market.
Shared demand assumptions, sales visibility, launch milestones and regular performance reviews support faster, better-informed decisions.
We build beyond launch day, supporting lifecycle planning, portfolio development, customer continuity and sustainable growth for both partners and practitioners.
01
Accountable partner
for India
for India
06
Connected stages from
strategy to sales
strategy to sales
India
Priority-market
distribution model
distribution model
360°
Commercial and
clinical activation
clinical activation
Connecting global innovation with India’s aesthetics ecosystem
Global Manufacturers◆
Aesthetic Pharma◆
Medical Device Companies◆
Professional Skincare◆
Dermatologists◆
Distribution Partners◆
Global Manufacturers◆
Aesthetic Pharma◆
Medical Device Companies◆
Professional Skincare◆
Dermatologists◆
Distribution Partners◆
05 / Build what’s next
Planning to enter or scale in India? Let’s map the journey.
Tell us where your brand is today. We’ll start with a practical conversation about regulatory readiness, market fit, distribution and the commercial path ahead.
Registered office
No. 011, Ground Floor, TMC Punarvasan
Ghodbunder Road, Kasarvadavali
Thane 400615, Maharashtra, India
Ghodbunder Road, Kasarvadavali
Thane 400615, Maharashtra, India
Business hours
Monday–Saturday
9:30 AM–6:30 PM IST
9:30 AM–6:30 PM IST
Phone
+91-6362181624
WhatsApp
+91-6362181624
Email
admin@biomeaesthetix.com